MPLA (PHAD(R))

Descrição detalhada : Vaccination is well-accepted as an effective method to prevent infections by mounting pathogen-specific immune responses prior to the infection. Usually, immunization with vaccine antigens alone is not able to induce robust or long-lasting immune responses - resulting in failure of protective immunity against infections. Thus, adjuvants are required to enhance cellular or humoral immune responses upon immunization. Because vaccine adjuvants using Lipid A have proven to be safe and effective in inducing Th-1 type immune responses to heterologous proteins in animal and human vaccines, Avanti developed Phosphorylated HexaAcyl Disaccharide (PHAD(R)), the first fully synthetic monophosphoryl Lipid A available for use as an adjuvant in human vaccines., Monophosphoryl lipid A (MPLA) is either extracted from bacterial lipid A or by chemical synthesis.
Sinónimos : PHAD(R) phosphorylated hexaacyl disaccharide; Glycopyranoside Lipid A; GLA
Fórmula molecula r: C96H184N3O22P
Armazenamento : -20C
Embalagem : 1X1MG